Poly Medicure [POLYMED] vs Shree Pacetronix [SHREEPAC] Detailed Stock Comparison

Poly Medicure

NSE
Loading...

Shree Pacetronix

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Poly Medicure wins in 11 metrics, Shree Pacetronix wins in 8 metrics, with 0 ties. Poly Medicure appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricPoly MedicureShree PacetronixBetter
P/E Ratio (TTM)56.0470.45Poly Medicure
Price-to-Book Ratio7.415.33Shree Pacetronix
Debt-to-Equity Ratio6.5236.79Poly Medicure
PEG Ratio2.920.88Shree Pacetronix
EV/EBITDA41.6728.70Shree Pacetronix
Profit Margin (TTM)21.18%6.03%Poly Medicure
Operating Margin (TTM)20.56%18.43%Poly Medicure
EBITDA Margin (TTM)20.56%18.43%Poly Medicure
Return on Equity12.24%5.44%Poly Medicure
Return on Assets (TTM)10.60%3.25%Poly Medicure
Free Cash Flow (TTM)$-906.06M$-7.25MShree Pacetronix
Dividend Yield0.33%N/AN/A
1-Year Return-11.80%34.37%Shree Pacetronix
Price-to-Sales Ratio (TTM)11.954.24Shree Pacetronix
Enterprise Value$190.64B$770.67MPoly Medicure
EV/Revenue Ratio11.294.46Shree Pacetronix
Gross Profit Margin (TTM)68.45%68.11%Poly Medicure
Revenue per Share (TTM)$168$48Poly Medicure
Earnings per Share (Diluted)$35.51$2.89Poly Medicure
Beta (Stock Volatility)0.04-1.61Shree Pacetronix
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Poly Medicure vs Shree Pacetronix Stock Performance Analysis

Loading Price Chart...

Poly Medicure
Shree Pacetronix
Poly Medicure Stock Overview | Shree Pacetronix Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Poly Medicure3.45%3.49%8.73%-3.29%-6.65%-22.93%
Shree Pacetronix1.98%10.34%44.26%180.52%213.50%70.48%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Poly Medicure-11.80%130.72%354.73%1,002.25%6,237.53%6,237.53%
Shree Pacetronix34.37%266.10%1,614.29%888.56%484.57%982.71%

News Based Sentiment: Poly Medicure vs Shree Pacetronix

Poly Medicure

News based Sentiment: POSITIVE

The acquisition of PendraCare is a significant strategic move for Poly Medicure, expanding its global reach and product portfolio in the cardiology sector. While there are some short-term revenue challenges, the long-term outlook appears positive, supported by analyst ratings and favorable regulatory changes.

View Poly Medicure News Sentiment Analysis

Shree Pacetronix

News based Sentiment: MIXED

Shree Pacetronix is experiencing strong positive price momentum, with a 10-day winning streak and a significant cumulative gain since August 4th. However, underlying financial health concerns regarding cash flow and capital allocation, highlighted in earlier September analysis, create a mixed investment picture. The upcoming October 17th earnings report will be crucial in determining whether the company can address these concerns and sustain its recent gains.

View Shree Pacetronix News Sentiment Analysis

Performance & Financial Health Analysis: Poly Medicure vs Shree Pacetronix

MetricPOLYMEDSHREEPAC
Market Information
Market Cap i₹201.64B₹747.42M
Market Cap CategoryLarge capSmall cap
10 Day Avg. Volume i166,88212,847
90 Day Avg. Volume i191,06317,079
Last Close₹2,065.40₹216.00
52 Week Range₹1,821.20 - ₹3,357.80₹61.11 - ₹216.00
% from 52W High-38.49%0.00%
All-Time High₹3,357.80 (Oct 28, 2024)₹391.90 (Nov 06, 2023)
% from All-Time High-38.49%-44.88%
Growth Metrics
Quarterly Revenue Growth0.05%0.10%
Quarterly Earnings Growth0.26%0.78%
Financial Health
Profit Margin (TTM) i0.21%0.06%
Operating Margin (TTM) i0.21%0.18%
Return on Equity (TTM) i0.12%0.05%
Debt to Equity (MRQ) i6.5236.79
Cash & Liquidity
Book Value per Share (MRQ)₹268.63₹38.18
Cash per Share (MRQ)₹119.26₹3.22
Operating Cash Flow (TTM) i₹2.95B₹-2,503,000
Levered Free Cash Flow (TTM) i₹3.39B₹7.50M
Dividends
Last 12-Month Dividend Yield i0.33%N/A
Last 12-Month Dividend i₹6.50₹0.00

Valuation & Enterprise Metrics Analysis: Poly Medicure vs Shree Pacetronix

MetricPOLYMEDSHREEPAC
Price Ratios
P/E Ratio (TTM) i56.0470.45
Forward P/E i259.11N/A
PEG Ratio i2.920.88
Price to Sales (TTM) i11.954.24
Price to Book (MRQ) i7.415.33
Market Capitalization
Market Capitalization i₹201.64B₹747.42M
Enterprise Value i₹190.64B₹770.67M
Enterprise Value Metrics
Enterprise to Revenue i11.294.46
Enterprise to EBITDA i41.6728.70
Risk & Other Metrics
Beta i0.04-1.61
Book Value per Share (MRQ) i₹268.63₹38.18

Financial Statements Comparison: Poly Medicure vs Shree Pacetronix

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)POLYMEDSHREEPAC
Revenue/Sales i₹4.03B₹53.43M
Cost of Goods Sold i₹1.27B₹17.04M
Gross Profit i₹2.76B₹36.39M
Research & Development i₹66.81MN/A
Operating Income (EBIT) i₹828.81M₹9.85M
EBITDA i₹1.49B₹11.81M
Pre-Tax Income i₹1.23B₹8.90M
Income Tax i₹298.63M₹2.26M
Net Income (Profit) i₹930.83M₹6.65M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)POLYMEDSHREEPAC
Cash & Equivalents i₹86.99M₹2.54M
Total Current Assets i₹19.17B₹171.89M
Total Current Liabilities i₹3.70B₹88.66M
Long-Term Debt i₹7.71M₹3.61M
Total Shareholders Equity i₹27.66B₹137.82M
Retained Earnings iN/AN/A
Property, Plant & Equipment i₹10.41B₹37.88M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)POLYMEDSHREEPAC
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPOLYMEDSHREEPAC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i166,88212,847
Average Daily Volume (90 Day) i191,06317,079
Shares Outstanding i101.33M3.60M
Float Shares i33.21M1.26M
% Held by Insiders i0.67%0.59%
% Held by Institutions i0.19%0.00%

Dividend Analysis & Yield Comparison: Poly Medicure vs Shree Pacetronix

MetricPOLYMEDSHREEPAC
Last 12-Month Dividend i₹6.50₹0.00
Last 12-Month Dividend Yield i0.33%N/A
3-Year Avg Annual Dividend i₹3.17₹0.00
3-Year Avg Dividend Yield i0.18%N/A
3-Year Total Dividends i₹9.50₹0.00
Ex-Dividend DateSep 18, 2025N/A